Used as a key chiral intermediate in the synthesis of biologically active pharmaceuticals, particularly in the development of selective receptor modulators. Its stereochemistry enables high enantioselectivity in drug candidates targeting central nervous system disorders. Commonly employed in the preparation of investigational compounds for treating neurological and psychiatric conditions due to its ability to influence neurotransmitter pathways. Also utilized in medicinal chemistry research for structure-activity relationship studies, where the (R)-enantiomer shows enhanced binding affinity compared to its counterpart.